Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
97% of our listeners don't realise they aren't followed, please double check, thank you!
Hosted by Thomas McMann, Making It In Manufacturing is ARTO's new in-person podcast series, spotlighting the leaders shaping the future of manufacturing, engineering and CDMOs in Life Sciences.
Each episode dives into the careers, decisions, and defining moments of industry mainstays - revealing the stories and insights behind real-world impact within the life science manufacturing and CDMO space.
If you're a leader in the space - or aspiring to be - this podcast is a must watch. The series is available on YouTube, Spotify, Apple Podcasts and all major platforms.
Hosted on Acast. See acast.com/privacy for more information.
| Episode | Date |
|---|---|
|
Inside the Race to Scale ADCs - Ian Glassford
|
May 07, 2026 |
|
How Samsung Biologics Is Redefining CDMO Partnerships - John Gagliardi
|
May 05, 2026 |
|
We Just Built a $1.5B Biologics Company… And We're Here to Disrupt the Industry - Joon Chang
|
Apr 28, 2026 |
|
From Lab Scientist to Pharma Leader: 40 Years of Scaling and Strategy Insight - Alison Clayton
|
Apr 23, 2026 |
|
This CDMO Has an Advantage No One Else Can Replicate - Quotient Sciences
|
Apr 22, 2026 |
|
The Hidden Challenges of Biologics Development - Dr. Adriana Kiędzierska-Mencfeld
|
Apr 21, 2026 |
|
Why CDMOs Must Scale Smarter - Peter Belden
|
Apr 16, 2026 |
|
Building a Pharma Company Is Harder Than You Think - David Stevens
|
Apr 16, 2026 |
|
The Hidden Challenges of Biologics Development - Dr. Adriana Kiędzierska-Mencfeld
|
Apr 10, 2026 |
|
This Model Could Replace Traditional CDMOs
|
Apr 09, 2026 |
|
The Truth About Automation in Modern Biomanufacturing - Daniel Shearer, FujiFilm
|
Mar 25, 2026 |
|
The Relentless Mindset Behind Scaling a Drug Manufacturing Company | Philippe Clavel
|
Mar 25, 2026 |
|
How Pharma Actually Sets Global Standards (GAMP Explained)
|
Mar 23, 2026 |
|
How Xellia Is Reshaping Europe’s Antibiotics Market | CEO Michael Kocher
|
Feb 26, 2026 |
|
The Untold Reality of Scaling Global Pharma Manufacturing - Xellia Pharmaceuticals
|
Feb 18, 2026 |
|
Inside Mabion’s Growth Strategy | CEO Gregor Kawaletz on Biosimilars & Biologics
|
Feb 12, 2026 |
|
Building Trust in Pharma and Biotech Manufacturing Partnerships | Sharp Services
|
Jan 29, 2026 |
|
What Makes a CDMO Investable? Ankit Gupta on Building Instapill for Long-Term Growth
|
Jan 16, 2026 |
|
Redefining Biomanufacturing: Himanshu Gadgil on Enzene’s Global CDMO Expansion
|
Jan 05, 2026 |
|
Scaling a Legacy CDMO: Inside Pyramid Pharma’s Fill-Finish Expansion
|
Dec 23, 2025 |
|
$45M Expansion: What’s Next for Argonaut’s Aseptic Manufacturing Capabilities
|
Dec 16, 2025 |
|
The CDMO Changing Oral Drug Delivery – Instapill CEO Ankit Gupta
|
Dec 15, 2025 |
|
How ten23 Became One of Europe’s Fastest-Growing Drug-Product CDMOs
|
Dec 11, 2025 |
|
How Do You Successfully Scale and Integrate CDMO Sites After Acquisition? J.D. Mowery
|
Dec 04, 2025 |
|
How a Crack in Equipment Taught Abbas Hussain the Value of Planning Buffers
|
Jul 24, 2025 |
|
How Michael Vrijs Defends His Site Against Auditors - Without Saying Too Much
|
Jul 10, 2025 |
|
Carsten Jasper: Revolutionising Pharma Compliance with AI, Cleanrooms & Bold Thinking
|
Jul 03, 2025 |
|
Simon Adams: Building Organisations That Can Withstand Change
|
Jun 26, 2025 |
|
Hazem Eleskandarani: Engineering Excellence in Global Pharmaceutical Quality
|
Jun 19, 2025 |
|
Hilary Mills-Baker: Championing Quality and Innovation in Life Sciences Automation
|
Jun 12, 2025 |